APA (7th ed.) Citation

J, L., KA, K., IK, G., P, I., M, H., S, G., . . . M, V. (2026). Metabolic dysfunction-associated steatotic liver disease and steatohepatitis-associated hepatocarcinoma preclinical models. Nature reviews. Gastroenterology & hepatology, 23(4), 286. https://doi.org/10.1038/s41575-025-01162-9

Chicago Style (17th ed.) Citation

J, Leslie, Krishnamurthy KA, Gopalsamy IK, Inacio P, Huch M, Gallage S, Oakley F, and Vacca M. "Metabolic Dysfunction-associated Steatotic Liver Disease and Steatohepatitis-associated Hepatocarcinoma Preclinical Models." Nature Reviews. Gastroenterology & Hepatology 23, no. 4 (2026): 286. https://doi.org/10.1038/s41575-025-01162-9.

MLA (9th ed.) Citation

J, Leslie, et al. "Metabolic Dysfunction-associated Steatotic Liver Disease and Steatohepatitis-associated Hepatocarcinoma Preclinical Models." Nature Reviews. Gastroenterology & Hepatology, vol. 23, no. 4, 2026, p. 286, https://doi.org/10.1038/s41575-025-01162-9.